Page 33 - 10 Most Trusted Diagnostic Companies in India 2022

ip
Un
Unipath USLL shed light on various inno- Dr Kushal Shah, Dr Meenu, Dr Viral
a
h
t
COMPANY OF THE MONTH
Shah, Dr Pankaj, Dr Ekta Jajodia , Dr
vations of the diagnostics leader,
its mission and achievements.
Kaushal joined hands with USLL and
Here are the edited excerpts:

of new areas like Next Generation

THE BEGINNINGS led the team to explore a variety
Sequencing to expand the brand’s
Speciality Laboratory Ltd. A young team of medical gradu- core expertise and create a
ates from CMC Vellore, led by Dr.
comprehensive diagnostics menu
Jwalant Shah (Director), with their to serve the Industry.
ON ITS WAY TO BECOMING INDIA’S PREFERRED HIGH-END DIAGNOSTICS persistence and determination, laid
BRAND the foundation of USLL in Ahmed-

Corporate Review | Pooja Kundoo CORE EXPERTISE AND

The country’s diagnostics sector abad in 2009 to bring a revolu- THE GROWING SCALE OF
has experienced a major reform tionary change in the diagnostics OPERATIONS
in the past decade and most vertical. Throughout the brand’s

relevantly, saw an acceleration journey, many leading names of USLL offers a wide array of diag-
during the pandemic phase. the industry like Dr Jwalant Shah, nostic tests viz. biochemistry,

The diagnostics sector has seen Dr. Apoorva Shah, Dr. Neeraj Arora, molecular diagnostics, cytopatho-
an influx of startups scaling their Dr Mohan Galande, Dr Amisha Shah, logy, histopathology, clinical chem-

operations and establishing them- istry, serology, haematopathology,
selves among the most prominent cytogenetic and microbiology. As

players in the sector. Standing
out among these, with its forward- per a report, USLL has 51 collec-

looking approach and technology tion centres and has also tied
penetration is Unipath Specialty up with 3,085 clinical labs as of

Laboratory Ltd. (USLL). Coupling September 30, 2020, at many
advanced laboratory science and Dr. Jwalant Shah | Director places in Gujarat and outside

futuristic technology, USLL estab- Gujarat. On a standalone basis, the
lished its name among the few in innovation and strong information revenue of the company grew by

commercializing several high-end systems, USLL has earned good 35% on a y-o-y basis during FY20
mainstream tests since its incep- will for its clinical excellence and

tion. Anchored by a qualified and accurate reporting. Speaking with backed by a 25% y-o-y increase
experienced senior management the Corporate Review, Dhruba- in the number of patients tested.

team with a well-defined organi- jyoti Bandyopadhyay, General Dhrubajyoti Bandyopadhyay | General “Our Advanced Technologies
sational structure, technology & Manager & Business Head of Manager & Business Head and Global Quality Systems have

|32 thecorporatereview.com | India | Vol. 3 | Issue 3 | March 2022 |33